课题基金基金详情
烟曲霉Cys(6)Zn(2)型转录因子LeuB家族调控亮氨酸合成网络和毒力的解析
结题报告
批准号:
31770086
项目类别:
面上项目
资助金额:
60.0 万元
负责人:
陆玲
依托单位:
学科分类:
C0104.微生物遗传与生物合成
结题年份:
2021
批准年份:
2017
项目状态:
已结题
项目参与者:
蒋鹤春、蔡振东、龙南彪、翟鹏飞、张驰、孙聪聪、岳尚、叶婧
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
解析病原真菌特有毒力基因及其调控网络将为新药靶的筛选和利用提供依据。烟曲霉中存在人源缺乏的亮氨酸合成途径,本课题的前期研究从烟曲霉随机突变体库中筛选到该途径中的Cys(6)Zn(2)型转录因子LeuB1,信息学分析表明LeuB家族有三个成员LeuB1,2,3但仅有LeuB1缺失导致低铁敏感、亮氨酸合成受阻、全局性蛋白降解。本课题拟进一步通过烟曲霉CRISPR-Cas9基因编辑技术,构建基因缺失、位点突变和原位加标签的LeuB系列菌株,研究LeuB家族调控亮氨酸合成的分子机制;并结合染色质免疫沉淀(ChIP-seq)、凝胶迁移分析(EMSA)证实LeuB家族转录调控的靶基因、探析LeuB家族及其转录活性与产生动物毒性的关系,进而阐明LeuB家族与亮氨酸合成的网络LeuA和LeuC的调控,解析LeuB家族影响烟曲霉生长发育和毒力的分子功能特征,为新型抗真菌药物设计提供理论依据。
英文摘要
New broad-spectrum antifungals, which display high effectiveness and reduced toxicity, are required. Since the nutrition of a pathogen during infection is essential for growth and maintenance within the host, new antifungals may be derived from the inhibition of fungal metabolism during pathogenesis. Therefore, targeting of pathways required for nutrient acquisition and metabolism could lead to new antifungals. Since mammals do not have the capacity to produce branched-chain amino acids, the fungal leucine biosynthesis system may be useful as a novel antifungal drug target. .In this project, based on screening T-DNA mutagenesis library, we found that the Cys(6)Zn(2) transcription factor family LeuB (LeuB1, 2 and 3) plays important roles in both leucine biosynthesis and iron regulation. According to BLAST analysis, LeuB1 in A. fumigatus has a deduced 920 amino acids sequence in length and belongs to a Cys(6)Zn(2) transcription factor family, which exclusively exists in fungi with a DNA-binding domain and a specific domain for a transcription factor. Deletion of leuB1 greatly reduces the hyphal growth rates and sharply decreases conidiation in the absence of leucine and/or under the iron starvation condition. These defects could be completely recovered with the addition of both leucine and iron in media. To further address how the leuB family regulates the leucine synthesis pathway and whether leuB family is an important virulence determinant in A. fumigatus, we will construct different strains including single and/or multiple leuB deletions, site-mutated, precise and efficient in-frame integration with GFP and His-tag based on homology-direct integration and a highly efficient CRISPR mutagenesis system. Through phenotypic observation under both liquid and solid cultural conditions, we next further clarify what is the relationship among this putative LeuB family members and how LeuB shows a dual-function transcription factor for both of leucine biosynthesis and the iron acquisition. Thirdly, according to approaches of Chip-seq (Chromatin Immunoprecipitation sequencing) combined with electrophoretic mobility shift assay (EMSA), putative target genes regulated by leuB as a potential transcript factor could be identified. Leucine is not only acts as a substrate for protein metabolism, but can also serve as signaling molecules during signal transduction. In eukaryote, proteasome mediated protein degradation pathway is crucial for the protein metabolism. Thus, we hypothesize that LeuB-deficiency resulted in dramatic protein degradation under iron starvation may be due to impaired leucine biosynthesis which activates the proteasome mediated protein degradation pathway. To verify this hypothesis, SDS-PAGE for whole protein extraction, Western blotting and related biochemistry assays will be carried out under the treatment of the proteasome specific inhibitor MG132 in vivo and in vitro. Finally, virulence tests for different leuB mutants will be carried out in both intranasally and intravenously infected mice model. We propose that the identification of LeuB-targeted genes with a yet uncharacterized link to leucine biosynthesis with iron as well as protein metabolism will aid in finding for new antifungal drug targets required for fungal adaption to host niches and virulence traits.
目前的抗真菌药主要靶点是真菌细胞壁和细胞膜,其中的唑类药物是临床一线药物之一。然而,日益加剧的侵袭性真菌感染和不断涌现的耐药菌株导致了可供选择的抗真菌药物的不足,因此,解析病原真菌特有毒力基因及其调控网络将为新药靶的筛选和利用提供依据。本课题的研究发现条件致病菌烟曲霉中存在人源缺乏的亮氨酸合成途径,该途径中的Cys(6)Zn(2)型转录因子LeuB家族有三个候选成员LeuB,B1, B2(现在命名为LeuB, 1, 2),它们均为Zn(II)2Cys6类型的转录因子。本课题按照计划通过烟曲霉CRISPR-Cas9基因编辑技术,构建基因缺失、位点突变和原位加标签的LeuB系列菌株,阐明了LeuB转录因子在亮氨酸合成调控中的功能;并结合染色质免疫沉淀(ChIP-seq)、凝胶迁移分析(EMSA)分析了LeuB的下游靶成员及其功能和调控途径,其中LeuB缺失导致低铁敏感、亮氨酸合成受阻、全局性的蛋白降解和大蜡螟和小鼠动物毒性显著降低(已发表)。另外,在项目执行期间,我们系统筛选了烟曲霉转录因子文库,发现了参与药物易感性以及烟曲霉毒性相关的重要转录因子和相关功能基因 (已发表)。更有意思的是,近期我们意外地发现缺铁环境下添加外源钙导致病原真菌烟曲霉的生长抑制现象,证实了高钙可以抑制真菌对于铁的吸收,从而加剧了铁的缺失,导致真菌生长停止。证实采用铁的螯合剂来降低铁营养的供给,同时结合一定浓度的钙营养,可以显著抑制烟曲霉的生长,这个抑制作用在培养基中和小鼠体内都得到证实。进一步发现高钙和低铁联合调节同样可以抑制病原真菌-白念珠菌和新生隐球菌的生长,这些发现暗示铁限制和高钙营养组合可以是一种新的抗菌策略,这个发现尤其对于目前难以治疗的耐药菌是一种新的策略(专利及待发表数据)。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1534/g3.118.200253
发表时间:2018-07-02
期刊:G3 (Bethesda, Md.)
影响因子:--
作者:Zhang C;Meng X;Gu H;Ma Z;Lu L
通讯作者:Lu L
DOI:10.1371/journal.pgen.1007762
发表时间:2018-10
期刊:PLoS genetics
影响因子:4.5
作者:Long N;Orasch T;Zhang S;Gao L;Xu X;Hortschansky P;Ye J;Zhang F;Xu K;Gsaller F;Straßburger M;Binder U;Heinekamp T;Brakhage AA;Haas H;Lu L
通讯作者:Lu L
DOI:10.1128/msphere.00670-18
发表时间:2019-01-01
期刊:MSPHERE
影响因子:4.8
作者:Cai, Zhendong;Du, Wenlong;Lu, Ling
通讯作者:Lu, Ling
DOI:10.1093/mmy/myy075
发表时间:2019
期刊:Medical Mycology
影响因子:--
作者:Li Yeqi;Zhang Yuanwei;Lu Ling
通讯作者:Lu Ling
Toxoflavin Produced by Burkholderia gladioli from Lycoris aurea Is a New Broad-Spectrum Fungicide
石蒜中的唐菖蒲伯克霍尔德杆菌产生的毒黄素是一种新型广谱杀菌剂
DOI:10.1128/aem.00106-19
发表时间:2019-05-01
期刊:APPLIED AND ENVIRONMENTAL MICROBIOLOGY
影响因子:4.4
作者:Li, Xiaodan;Li, Yikui;Lu, Ling
通讯作者:Lu, Ling
烟曲霉钙调磷酸酶参与的液泡 (Vacuole) 钙信号调控网络作为新型抗真菌药物靶点的探索
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    55万元
  • 批准年份:
    2021
  • 负责人:
    陆玲
  • 依托单位:
烟曲霉钙调磷酸酶参与的液泡(Vacuole)钙信号调控网络作为新型抗真菌药物靶点的探索
  • 批准号:
    82172292
  • 项目类别:
    面上项目
  • 资助金额:
    55.00万元
  • 批准年份:
    2021
  • 负责人:
    陆玲
  • 依托单位:
构巢曲霉形态建成调节网-SIN途径反向调节子(Suppressor)对于胞质分裂的调控机制
  • 批准号:
    31370112
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    陆玲
  • 依托单位:
曲霉中钙信号通路参与的唑类药物多药耐药的分子调控机制
  • 批准号:
    81330035
  • 项目类别:
    重点项目
  • 资助金额:
    290.0万元
  • 批准年份:
    2013
  • 负责人:
    陆玲
  • 依托单位:
逆境胁迫诱导构巢曲霉RAM缺失菌株极性生长恢复的转录调控机制研究
  • 批准号:
    31070031
  • 项目类别:
    面上项目
  • 资助金额:
    40.0万元
  • 批准年份:
    2010
  • 负责人:
    陆玲
  • 依托单位:
Ca2+-CaM信号系统与丝状真菌中人辅肌动蛋白alpha-actinin同源基因对极性生长调控的分子机理
  • 批准号:
    30770031
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2007
  • 负责人:
    陆玲
  • 依托单位:
AnMOB1在构巢曲霉胞质分裂信号传导中的功能及其胞内运输
  • 批准号:
    30570930
  • 项目类别:
    面上项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2005
  • 负责人:
    陆玲
  • 依托单位:
国内基金
海外基金